FDA Cites Buenos Aires API Facility for Records, Equipment Calibration

The FDA rapped Umicore Argentina for violations relating to its control procedures and equipment calibration, following a May inspection of the API manufacturer’s Buenos Aires facility.
Source: Drug Industry Daily